NCT00606866
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- The University of Chicago Chicago, Illinois, United States
Clinical trial condition
Metastatic Renal Cell Carcinoma
Explore clinical trials studying Metastatic Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.
126 public trials
24 recruiting studies
Metastatic Renal Cell Carcinoma trial results
NCT02599324
- Conditions
- Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Urothelial Carcinoma, +17 more
- Locations
-
- Clearview Cancer Institute /ID# 1128-0965 Huntsville, Alabama, United States
- Banner MD Anderson Cancer Center /ID# 1128-0802 Gilbert, Arizona, United States
- University of Arizona Cancer Center - Tucson /ID# 1128-1546 Tucson, Arizona, United States
- Alta Bates Comprehensive Cancer Center /ID# 1128-0135 Berkeley, California, United States
NCT01517243
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
- University of Vermont, Vermont Cancer Center Burlington, Vermont, United States
NCT03200717
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
- Novartis Investigative Site Caba, Buenos Aires, Argentina
- Novartis Investigative Site Graz, Austria
- Novartis Investigative Site Salzburg, Austria
NCT01689766
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- Baylor College of Medicine Houston, Texas, United States
NCT00068393
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- University of Colorado Cancer Center at UC Health Sciences Center Aurora, Colorado, United States
- Rush-Copley Cancer Care Center Aurora, Illinois, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
NCT01689662
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Baylor College of Medicine Houston, Texas, United States
Completed
Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib
NCT04076787
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of Calgary Calgary, Alberta, Canada
NCT03428217
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Mayo Clinic Cancer Center Phoenix, Arizona, United States
- The University of Arizona Cancer Center Tucson, Arizona, United States
- Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
NCT00142415
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University Medical Center Nijmegen Nijmegen, Netherlands